🇺🇸 FDA
Patent

US 11598782

Biomarkers and methods for detection of seizures and epilepsy

granted A61KA61K31/195A61K31/20

Quick answer

US patent 11598782 (Biomarkers and methods for detection of seizures and epilepsy) held by Cognizance Biomarkers, LLC expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cognizance Biomarkers, LLC
Grant date
Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/195, A61K31/20, A61K31/27, A61K31/4015